Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 61176 - 61200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Pyrithione	Approved Investigational	HSPA1L	3305	upregulated	pyrithione zinc results in increased expression of HSPA1L mRNA	6p21.33	A23729 A23728
Pyrithione	Approved Investigational	HSPA4	3308	upregulated	pyrithione zinc results in increased expression of HSPA4 mRNA	5q31.1	A23728
Pyrithione	Approved Investigational	HSPA5	3309	upregulated	pyrithione zinc results in increased expression of HSPA5 mRNA	9q33.3	A23728
Pyrithione	Approved Investigational	HSPA6	3310	upregulated	pyrithione zinc results in increased expression of HSPA6 mRNA	1q23.3	A23729 A23728
Pyrithione	Approved Investigational	HSPA8	3312	upregulated	pyrithione zinc results in increased expression of HSPA8 mRNA	11q24.1	A23728
Pyrithione	Approved Investigational	HSPD1	3329	upregulated	pyrithione zinc results in increased expression of HSPD1 mRNA	2q33.1	A23728
Pyrithione	Approved Investigational	HSPE1	3336	upregulated	pyrithione zinc results in increased expression of HSPE1 mRNA	2q33.1	A23728
Pyrithione	Approved Investigational	HSPH1	10808	upregulated	pyrithione zinc results in increased expression of HSPH1 mRNA	13q12.3	A23728
Pyrithione	Approved Investigational	IGFBP6	3489	downregulated	pyrithione zinc results in decreased expression of IGFBP6 mRNA	12q13.13	A23728
Pyrithione	Approved Investigational	LTA	4049	upregulated	pyrithione zinc results in increased expression of LTA mRNA	6p21.33	A23728
Pyrithione	Approved Investigational	MDM2	4193	upregulated	pyrithione zinc results in increased expression of MDM2 mRNA	12q15	A23728
Pyrithione	Approved Investigational	MT2A	4502	upregulated	pyrithione zinc results in increased expression of MT2A mRNA	16q13	A23730 A23728
Pyrithione	Approved Investigational	NFKB1	4790	upregulated	pyrithione zinc results in increased expression of NFKB1 mRNA	4q24	A23728
Pyrithione	Approved Investigational	NFKBIA	4792	downregulated	pyrithione zinc results in decreased expression of NFKBIA mRNA	14q13.2	A23728
Pyrithione	Approved Investigational	POR	5447	downregulated	pyrithione zinc results in decreased expression of POR mRNA	7q11.23	A23728
Pyrithione	Approved Investigational	PRDX1	5052	upregulated	pyrithione zinc results in increased expression of PRDX1 mRNA	1p34.1	A23728
Pyrithione	Approved Investigational	PTGS1	5742	downregulated	pyrithione zinc results in decreased expression of PTGS1 mRNA	9q33.2	A23728
Pyrithione	Approved Investigational	RAD23A	5886	upregulated	pyrithione zinc results in increased expression of RAD23A mRNA	19p13.13	A23728
Pyrithione	Approved Investigational	RAD50	10111	upregulated	pyrithione zinc results in increased expression of RAD50 mRNA	5q31.1	A23728
Pyrithione	Approved Investigational	SERPINE1	5054	downregulated	pyrithione zinc results in decreased expression of SERPINE1 mRNA	7q22.1	A23728
Pyrithione	Approved Investigational	SOD1	6647	upregulated	pyrithione zinc results in increased expression of SOD1 mRNA	21q22.11	A23728
Pyrithione	Approved Investigational	SOD2	6648	upregulated	pyrithione zinc results in increased expression of SOD2 mRNA	6q25.3	A23728
Pyrithione	Approved Investigational	TNF	7124	upregulated	pyrithione zinc results in increased expression of TNF mRNA	6p21.33	A23728
Pyrithione	Approved Investigational	TP53	7157	upregulated	pyrithione zinc results in increased expression of TP53 mRNA	17p13.1	A23728
Pyrithione	Approved Investigational	UNG	7374	upregulated	pyrithione zinc results in increased expression of UNG mRNA	12q24.11	A23728

Displaying entries 61176 - 61200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability